We are live on ! Find out more
BOLD

Boundless Bio

55 hedge funds and large institutions have $46.1M invested in Boundless Bio in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 4

17% more funds holding

Funds holding: 4755 (+8)

2.54% less ownership

Funds ownership: 62.18%59.64% (-2.5%)

14% less capital invested

Capital invested by funds: $53.4M → $46.1M (-$7.37M)

35% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 17

Holders
55
Holders Change
+8
Holders Change %
+17.02%
% of All Funds
0.79%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
11
Reduced
17
Closed
4
Calls
Puts
Net Calls
Net Calls Change

BOLD Hedge Fund Activity: Q3 2024 in Review

55 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Boundless Bio (BOLD) for Q3 2024, worth a combined $46.1M — down 14% from $53.4M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BOLD positions and 4 closed out — a net gain of 8 holders — while 11 added to existing stakes and 17 trimmed.

The largest buyer was Vanguard Group, adding an estimated $618K. The largest seller was Millennium Management, exiting entirely with an estimated $908K sold.

  • 55 institutional investors held Boundless Bio (BOLD) as of Q3 2024, up from 47 in Q2 2024.
  • Funds reported $46.1M of Boundless Bio stock for Q3 2024, down 14% quarter-over-quarter.
  • 12 funds opened new Boundless Bio positions in Q3 2024 and 4 closed out, a net change of +8 holders.
  • The largest Boundless Bio buyer in Q3 2024 was Vanguard Group, an estimated $618K added.
  • The largest Boundless Bio seller in Q3 2024 was Millennium Management, an estimated $908K sold.

Based on aggregated 13F filings for Q3 2024.